1. Home
  2. BCTX vs NUR Comparison

BCTX vs NUR Comparison

Compare BCTX & NUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BriaCell Therapeutics Corp.

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$4.10

Market Cap

31.1M

Sector

Health Care

ML Signal

HOLD

NUR

Nuran Wireless Inc. Common Shares

N/A

Current Price

$1.01

Market Cap

25.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
BCTX
NUR
Founded
2014
N/A
Country
Canada
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.1M
25.2M
IPO Year
2025
2016

Fundamental Metrics

Financial Performance
Metric
BCTX
NUR
Price
$4.10
$1.01
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$40.00
N/A
AVG Volume (30 Days)
243.4K
4.0M
Earning Date
06-15-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$380.95
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.60
$0.95
52 Week High
$14.68
$7.72

Technical Indicators

Market Signals
Indicator
BCTX
NUR
Relative Strength Index (RSI) 63.59 32.17
Support Level $4.10 $0.95
Resistance Level $4.38 $7.72
Average True Range (ATR) 0.20 0.63
MACD 0.05 -0.09
Stochastic Oscillator 78.49 1.13

Price Performance

Historical Comparison
BCTX
NUR

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: